• BVF Partners sold 1,630,658 Kymera Therapeutics common shares on June 26, 2026 at USD 106.5 each.
• Holdings fell to 1,960,881 shares for BVF, 1,592,261 shares for BVF2, 240,123 shares for Trading Fund OS.
• Partners managed account cut its stake by 51,858 shares to 78,787 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000921895-26-001688), on June 26, 2026, and is solely responsible for the information contained therein.